Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine for cognitive and behavioral disorders after chronic severe traumatic brain injury
2006-004435-30Phase 4Active
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rivastigmine in traumatic brain injury (TBI), acquired brain injury (ABI), cognitive disorder (CD) and 1 more, sponsored by Fondazione Santa Lucia IRCCS. Primary endpoint: Family, social and work re-entry. Started Apr 2007; status: active.
02
Drugs
rivastigmine
03
Conditions
traumatic brain injury (TBI)acquired brain injury (ABI)cognitive disorder (CD)behavioral disorder
Beyond the preview
Go deeper on 2006-004435-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004435-30.